tradingkey.logo
tradingkey.logo
Search

Novartis AG

NVS
Add to Watchlist
156.150USD
+3.070+2.01%
Close 07-23 16:00ETQuotes delayed by 15 min
296.80BMarket Cap
22.22P/E TTM

NVS Financials

See Novartis AG's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Novartis AG Earnings Date

Latest Release
Jul 21, 2026
EPS / Forecast
1.71/2.36
Revenue / Forecast
14.95B/14.50B
Period
FY2025 Earnings
Revenue(YoY)
56.33B
8.91%
EPS(YoY)
7.21
21.88%
Analyst Rating
HOLD
2026/07/23
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
-17.40%1.71
-10.10%1.65
-11.39%1.26
28.67%2.04
29.92%2.07
39.33%1.83
-65.63%1.42
85.59%1.58
43.60%1.60
21.01%1.32
501.83%4.13
--0.85
--1.11
--1.09
--0.69
--2.50
----
----
----
----
Revenue
2.88%14.95B
-0.54%13.51B
2.23%13.86B
9.00%14.36B
12.86%14.53B
12.09%13.59B
15.13%13.56B
8.93%13.17B
9.60%12.87B
9.71%12.12B
8.24%11.78B
12.14%12.09B
-10.24%11.74B
-13.79%11.05B
135.55%10.88B
-19.33%10.78B
-1.57%13.09B
0.95%12.81B
-64.55%4.62B
6.61%13.37B
Net Profit
-19.23%3.26B
-12.48%3.16B
-14.51%2.41B
23.17%3.93B
24.49%4.04B
34.15%3.61B
-66.77%2.82B
81.09%3.19B
40.16%3.25B
17.23%2.69B
478.44%8.48B
11.95%1.76B
36.72%2.32B
3.20%2.29B
-91.01%1.47B
-42.97%1.57B
-41.51%1.69B
7.92%2.22B
678.80%16.31B
42.53%2.76B
Net Margin
-21.33%21.79%
-12.07%23.36%
-16.61%17.34%
13.20%27.37%
9.84%27.70%
19.78%26.57%
-7.15%20.80%
93.25%24.18%
30.42%25.22%
13.95%22.18%
85.34%22.40%
--12.51%
--19.34%
--19.46%
--12.09%
--14.57%
----
----
----
----
Gross Margin
-2.28%75.39%
-2.25%74.55%
-1.47%74.44%
-0.02%75.38%
2.35%77.15%
2.38%76.27%
1.24%75.56%
1.58%75.39%
5.36%75.38%
2.16%74.50%
3.59%74.63%
--74.22%
--71.55%
--72.92%
--72.05%
--73.72%
----
----
----
----
Debt to assets ratio
29.28%40.07%
26.70%39.53%
4.30%31.88%
-3.92%29.78%
4.46%31.00%
8.22%31.20%
15.97%30.57%
39.03%30.99%
16.36%29.67%
11.00%28.83%
10.94%26.36%
--22.29%
--25.50%
--25.97%
--23.76%
--24.01%
----
----
----
----
Revenue
2.88%14.95B
-0.54%13.51B
2.23%13.86B
9.00%14.36B
12.86%14.53B
12.09%13.59B
15.13%13.56B
8.93%13.17B
9.60%12.87B
9.71%12.12B
8.24%11.78B
12.14%12.09B
-10.24%11.74B
-13.79%11.05B
135.55%10.88B
-19.33%10.78B
-1.57%13.09B
0.95%12.81B
-64.55%4.62B
6.61%13.37B
Operating profit
0.00%5.16B
-14.09%4.11B
-0.81%4.06B
5.71%4.59B
22.81%5.16B
28.01%4.79B
36.57%4.10B
25.64%4.35B
26.01%4.20B
28.82%3.74B
9.49%3.00B
55.95%3.46B
0.30%3.33B
-10.73%2.90B
139.72%2.74B
-37.27%2.22B
-2.35%3.32B
8.29%3.25B
-56.92%1.14B
6.31%3.54B
Net Profit
-19.23%3.26B
-12.48%3.16B
-14.51%2.41B
23.17%3.93B
24.49%4.04B
34.15%3.61B
-66.77%2.82B
81.09%3.19B
40.16%3.25B
17.23%2.69B
478.44%8.48B
11.95%1.76B
36.72%2.32B
3.20%2.29B
-91.01%1.47B
-42.97%1.57B
-41.51%1.69B
7.92%2.22B
678.80%16.31B
42.53%2.76B
Current assets
5.44%27.35B
5.97%26.61B
2.55%30.46B
-9.81%28.20B
0.96%25.94B
-5.06%25.11B
-2.55%29.70B
-31.53%31.26B
-23.29%25.69B
-17.65%26.45B
-17.42%30.48B
23.56%45.66B
-12.19%33.49B
-13.76%32.11B
-19.27%36.91B
40.76%36.95B
60.21%38.14B
67.74%37.24B
54.07%45.72B
-9.39%26.25B
Total current liabilities
0.11%31.75B
-0.77%31.37B
-4.93%27.28B
13.75%32.00B
14.86%31.71B
7.96%31.62B
8.72%28.69B
-41.87%28.13B
-13.47%27.61B
-4.13%29.29B
-7.91%26.39B
71.85%48.39B
15.42%31.91B
2.49%30.55B
-5.14%28.66B
-5.76%28.16B
-6.71%27.65B
-1.17%29.81B
-8.62%30.21B
-6.15%29.88B
Total assets
16.90%122.03B
18.60%118.53B
8.51%110.95B
3.64%107.29B
7.07%104.39B
5.94%99.94B
2.30%102.25B
-8.14%103.52B
-12.14%97.50B
-15.95%94.33B
-14.91%99.94B
-4.87%112.70B
-9.71%110.98B
-10.36%112.24B
-10.88%117.45B
-2.26%118.46B
-0.89%122.91B
2.85%125.22B
3.14%131.79B
-6.53%121.21B
Total liabilities
28.47%80.09B
29.46%79.61B
10.81%64.40B
4.08%62.54B
12.12%62.34B
12.66%61.49B
9.26%58.12B
-19.30%60.08B
-5.83%55.60B
-9.19%54.58B
-8.33%53.20B
29.33%74.45B
-1.43%59.05B
-5.38%60.10B
-9.29%58.03B
-10.43%57.57B
-14.28%59.90B
-10.75%63.51B
-10.04%63.97B
-14.45%64.27B
Total equity
-0.26%41.95B
1.24%38.93B
5.49%46.55B
3.02%44.75B
0.36%42.05B
-3.28%38.45B
-5.61%44.13B
13.59%43.44B
-19.31%41.90B
-23.75%39.76B
-21.33%46.75B
-37.20%38.24B
-17.58%51.93B
-15.50%52.14B
-12.38%59.42B
6.96%60.90B
16.40%63.01B
21.97%61.70B
19.69%67.82B
4.37%56.94B
Net operating income
-11.73%5.88B
0.85%3.68B
-46.01%2.26B
4.53%6.57B
36.70%6.66B
60.93%3.65B
64.63%4.19B
18.51%6.29B
36.33%4.88B
-23.40%2.27B
-38.04%2.55B
12.35%5.30B
-4.77%3.58B
79.32%2.96B
5.84%4.11B
-4.14%4.72B
-9.12%3.75B
-22.58%1.65B
-3.02%3.88B
56.05%4.92B
Net investment
-38.43%-3.10B
-3656.36%-11.74B
30.63%-2.10B
-129.95%-860.00M
30.06%-2.24B
136.71%330.00M
-196.77%-3.03B
81.34%-374.00M
-204.56%-3.21B
-108.46%-899.00M
30.33%-1.02B
-138.55%-2.00B
90.94%-1.05B
13.41%10.62B
-132.15%-1.47B
519.87%5.20B
-11965.31%-11.63B
1092.99%9.37B
901.93%4.56B
38.86%-1.24B
Net financing
61.25%-2.02B
141.87%3.58B
156.17%1.68B
-630.10%-2.79B
-62.91%-5.21B
-65.53%-8.55B
-504.03%-3.00B
91.13%-382.00M
12.02%-3.20B
43.88%-5.16B
87.58%-496.00M
9.12%-4.31B
-57.99%-3.64B
3.42%-9.20B
-22.85%-3.99B
-206.07%-4.74B
21.59%-2.30B
-11.71%-9.53B
-11.22%-3.25B
-181.00%-1.55B

FAQs

What is the total revenue of Novartis AG?

According to Novartis AG's FY2025 earnings report, its total revenue reached 56.33B, with a year-on-year change of 51.72B.

What are the current assets of Novartis AG?

According to Novartis AG's FY2025 earnings report, its current assets were 30.46B, with a year-on-year change of 2.55.

What are the total assets of Novartis AG?

According to Novartis AG's FY2025 earnings report, its total assets of Novartis AG were 110.95B, with a year-on-year change of 8.51.

What are the total liabilities of Novartis AG?

According to Novartis AG's FY2025 earnings report, its total liabilities of Novartis AG were 64.40B, with a year-on-year change of 10.81.

What is the total equity of Novartis AG?

According to Novartis AG's FY2025 earnings report, its total equity of Novartis AG was 46.55B, with a year-on-year change of 5.49.

What is the net operating income of Novartis AG?

According to Novartis AG's FY2025 earnings report, its net operating income of Novartis AG was 18.61B, with a year-on-year change of 13.71.

What is the net investment of Novartis AG?

According to Novartis AG's FY2025 earnings report, its net investment of Novartis AG was -4.88B, with a year-on-year change of 35.09.

What is the net financing of Novartis AG?

According to Novartis AG's FY2025 earnings report, its net financing of Novartis AG was -14.87B, with a year-on-year change of -26.61.

What is the Earnings Per Share (EPS) of Novartis AG?

According to Novartis AG's FY2025 earnings report, its Earnings Per Share (EPS) was 7.21, with a year-on-year change of 21.88.

What is the net income of Novartis AG?

According to Novartis AG's FY2025 earnings report, its net income was 13.98B, with a year-on-year change of 17.11.

What is the net margin of Novartis AG?

According to Novartis AG's FY2025 earnings report, its net profit margin was 24.79, with a year-on-year change of 7.42.

What is the gross margin of Novartis AG?

According to Novartis AG's FY2025 earnings report, its gross margin was 75.82, with a year-on-year change of 0.79.

What is the debt-to-asset ratio of Novartis AG?

According to Novartis AG's FY2025 earnings report, its debt-to-asset ratio was 31.88, with a year-on-year change of 4.30.

What is the Return on Equity (ROE) of Novartis AG?

According to Novartis AG's FY2025 earnings report, its Return on Equity (ROE) was 31.01, with a year-on-year change of 17.81.

What is the Return on Assets (ROA) of Novartis AG?

According to Novartis AG's FY2025 earnings report, its Return on Assets (ROA) was 13.10, with a year-on-year change of 10.95.

What is the operating profit of Novartis AG?

According to Novartis AG's FY2025 earnings report, its operating profit was 18.61B, with a year-on-year change of 13.71.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.